Comorbidity in lung cancer patients Source: Annual Congress 2010 - Best supportive care and palliation for lung cancer patients Year: 2010
Clinical factors of long-term survival in patients with advanced lung cancer Source: International Congress 2017 – Lung cancer: clinically relevant aspects of epidemiology, co-morbidities, metastasised disease and follow-up Year: 2017
Clinical characteristics, treatment, and prognosis of lung cancer elderly patients Source: Eur Respir J 2001; 18: Suppl. 33, 228s Year: 2001
The survival in elderly patients after resection of lung cancer Source: Annual Congress 2008 - Congenital lung lesions and emphysema; lung cancer surgery Year: 2008
Assessment of comorbidity in newly diagnosed lung cancer patients Source: Annual Congress 2009 - Clinical aspects and epidemiology in lung cancer Year: 2009
Clinical impact of steps-count during hospitalization after surgery in lung cancer patients Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019
Epidemiological and clinical predictors of survival during the first year of the treatment in non-small cell lung cancer patients Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009
Comorbidity and risk factors in patients undergoing a pneumonectomy procedure as treatment for lung cancer Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology Year: 2010
The effect of nutritional indicators on prognosis of patients with advanced lung cancer Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology Year: 2019
Brain metastasis as initial presentation of lung cancer - Impact of prognostic factors on patient survival Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside Year: 2017
Influence of anxiety and depression on one-year survival in lung cancer patients Source: International Congress 2016 – Quality management and quality of life in lung cancer Year: 2016
Trends in drug costs and overall survival in patients diagnosed with metastatic non-small cell lung cancer (NSCLC) Source: International Congress 2019 – How to guide patients to reach a balance between costs and personal needs: quality indicators of effectiveness Year: 2019
Effect of cardiovascular comorbidities on the survival patients with stage I and II non-small-cell lung cancer Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer Year: 2011
Attempting tissue diagnosis in performance status 3 and 4 lung cancer patients may not influence treatment or survival Source: Annual Congress 2013 –Quality management in thoracic oncology Year: 2013
Effect of autoimmune diseases on risk and survival in histology-specific lung cancer Source: Eur Respir J 2012; 40: 1489-1495 Year: 2012
Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment Source: Virtual Congress 2021 – Therapy of lung cancer Year: 2021
Age related influence of COPD on postoperative pulmonary morbidity in lung cancer patients Source: Annual Congress 2013 –Oncological thoracic surgery Year: 2013
Effect of comorbidity on the prognosis of non-small cell lung cancer Source: Eur Respir J 2006; 28: Suppl. 50, 385s Year: 2006
Performance status as predictor factor of quality of life in patients with non-small cell lung cancer Source: Eur Respir J 2004; 24: Suppl. 48, 75s Year: 2004
Emergency presentation of lung cancer patients via A&E increases the chances of having advanced disease stage and worse performance status Source: International Congress 2017 – Noteworthy lung cancer patient reports: reported outcome measures, smoking cessation, weight and sleep disorders Year: 2017